Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

Updates regarding government operating status and resumption of normal operations can be found at

Clinical Islet Transplantation Consortium (CITC)

The Clinical Islet Transplantation Consortium is a network of clinical centers and a data coordinating center established in 2004 to conduct studies of islet transplantation in patients with type 1 diabetes.

Main Areas of Focus

  • To improve the isolation and viability of islets
  • To reduce complications of the islet transplant procedure (e.g., bleeding and clotting in the blood vessels of the liver)
  • To reduce the side effects of immunosuppression
  • To achieve good blood sugar control without hypoglycemia
  • To follow the fate of islets after transplantation and determining why donor islets sometimes fail
  • To evaluate new ways to safely prevent immune rejection of donor tissues
Content last reviewed on November 17, 2017